Characteristics of Pain in Parkinson’s Disease with Arabic translation and validation of King’s Parkinson’s Disease Pain Scale
Objective: To translate and validate the King’s Parkinson’s Disease Pain Scale (KPPS) into Arabic and to correlate pain among PD patients with motor and non-motor…A strategic training framework for building research capacity in the Global Parkinson’s Genetics Program (GP2)
Objective: To promote and facilitate learning internationally with resources and expertise to serve the training needs of the Global Parkinson’s Genetics Program (GP2;www.gp2.org) and its…Dopamine dysregulation syndrome in Parkinson’s disease controlled by safinamine
Objective: To describe a case of dopamine dysregulation syndrome managed by safinamide. Background: Dopamine dysregulation syndrome (DDS) is an uncommon non-motor symptom of Parkinson disease…Atypical parkinsonism and psychiatric disorder in hereditary diffuse leukoencephalopathy with spheroids: a novel variant in the CSF1R gene
Objective: We describe the clinical, radiological and neuropathological phenotype of a patient carrying a novel variant in the CSF1R gene. Background: Hereditary diffuse leukoencephalopathy with…Long-term dementia prevalence in Parkinson disease: Glass half-full?
Objective: To determine long-term, cumulative dementia prevalence rates in Parkinson disease (PD) using data from two large, ongoing, prospective observational studies. Background: Dementia is reported to occur in…Early onset of efficacy during titration in US phase 3 open-label InfusON trial of apomorphine subcutaneous infusion for Parkinson’s disease motor fluctuations
Objective: Evaluate safety/onset of efficacy during titration of continuous subcutaneous apomorphine infusion (CSAI) for motor fluctuations in U.S. outpatients with Parkinson’s disease (PD). Background: Global…COPS: Continuous Observation of Parkinsonian Symptoms – A prospective data acquisition study using wearable accelerometery
Objective: To investigate the continuous and objective assessment of motor symptom severity in Parkinson’s Disease (PD) in everyday life. Background: Treatment adjustments in PD patients…Neurite Orientation Dispersion and Density Imaging and Diffusion Kurtosis Imaging in Brainstem Nuclei for Subtypes of Parkinson’s Disease
Objective: We utilized neurite orientation dispersion and density imaging (NODDI) along with diffusion tensor and kurtosis imaging (DTI/DKI) to assess brainstem nuclei in Parkinson’s disease…Epidemiological analysis of autosomal dominant chorea in Eastern Algeria
Objective: We aim to analyze the main epidemiological characteristics of individuals having a Huntington disease phenotype in Eastern Algeria population. Background: Huntington's disease (HD) is…Validity and Reliability of the Turkish Version of the Radboud Oral Motor Inventory for Parkinson’s Disease (ROMP)
Objective: The aim of this study is to evaluate the validity and reliability of the Turkish version of ROMP for use in clinical settings. Background:…
- « Previous Page
- 1
- …
- 36
- 37
- 38
- 39
- 40
- …
- 186
- Next Page »